HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

5-Fluoro-2'-deoxyuridine

HCID 3363
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
2968-28-7
Standard SMILES
O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F
InChIKey
ODKNJVUHOIMIIZ-UHFFFAOYSA-N
Molecular formula
C9H11FN2O5
Average molar mass
246.19 g/mol
Monoisotopic mass
246.06519967

Overview

5-fluoro-1-[4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]pyrimidine-2,4-dione is a pyrimidine 2'-deoxyribonucleoside.

Names & identifiers

Preferred name
5-Fluoro-2'-deoxyuridine
IUPAC
5-fluoro-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
English name
Floxuridine
Molecular formula
C9H11FN2O5
Molecular weight
246.19

Names & synonyms

5-Fluoro-2'-deoxyuridineDTXSID70274397RefChem:913372DTXCID402258765-fluoro-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione2968-28-71397179-21-35-fluoro-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione5-fluoro-1-[4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4(1H,3H)-dioneRo 5-0360(+)-5-fluoro-2'-deoxyuridineUridine, 2'-deoxy-5'-fluoro-
Show more names
FUDRFDUR5-FLUORODEOXYURIDINE5-FUDR5-Fluoro-1-((2R,4S,5R)-4-hydroxy-5-(hydroxyMethyl)tetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione5-FLUORO-2-DEOXYURIDINE2'-Deoxy-5-fluorouridineFUDFloxuridinfluorodeoxyuridine
floxuridine (fudr)2'-Deoxy-5-fluoro-uridinNeuro_000015CHEMBL6628NCIOpen2_002917SCHEMBL2050487SCHEMBL27146731CHEBI:94445

Properties

Computed structural properties

XLogP
-1.2
Topological polar surface area
99.1 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
6
Rotatable bonds
2
Heavy atoms
17
Formal charge
0
Complexity
386

Physicochemical properties

Melting point
148 °C · 148 °C(lit.)
Boiling point
150 °C · 150 °C
alpha
35.9 · 35.9 º (c=1, water)
Density
1.3751 · 1.3751 (estimate)
storage temp.
room temp
solubility
100 mM · Soluble to 100 mM in water and to 100 mM in DMSO
pka
7.44 · pKa 7.44 (Uncertain)
form
Powder
color
White to almost white
biological source
synthetic (organic)
Water Solubility
soluble
Merck
14 · 14,4112
BRN
2645818 · 2645818
Stability
Stable. Incompatible with strong oxidizing agents.
Major Application
pharmaceutical small molecule
InChI
1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

F
10-23
wgk
3
rtecs
YU7525000
ridadr
UN 2811 6.1/PG 3
hs_code
29349990
Toxicity
LD50 oral in rat: 215mg/kg
risk_code
22-68-36/37/38-40-20/21/22
Signal word
Danger
Symbol(GHS)
GHS06
hazard_code
Xn,T,Xi
hazard_note
Toxic
safety_code
22-36-36/37/39-26
hazard_class
6.1
Storage Class
6.1D - Non-combustible acute toxic Cat.3toxic hazardous materials or hazardous materials causing chronic effects
packing_group
III
Hazard statements
H301
Hazard Classifications
Acute Tox. 3 Oral
Precautionary statements
P264-P270-P301+P310-P405-P501
Hazardous Substances Data
50-91-9(Hazardous Substances Data)

Chemistry & industry

Applications · 6 items

DescriptionFloxuridine is a nucleoside analog that inhibits the enzyme ribonucleotide reductase, which is involved in the synthesis of DNA. Floxuridine has been shown to inhibit the growth of cancer cells and induce apoptosis in vivo. Floxuridine has also been shown to inhibit tumor growth in animal models by inhibiting the production of reactive oxygen species and upregulating tumor suppressor genes, such as p53. This drug also has inhibitory effects on enzymes that are involved in cell proliferation, such as protein kinase C and tyrosine kinases.

UsesFloxuridine USP is used in Palliative treatment of gastrointestinal adenocarcinoma with liver metastases.

UsesAntiviral; antineoplastic.

Usesrenal function diagnosis

General DescriptionThe drug is available as a 500-mg vial of lyophilized powder.The drug is used to treat metastatic GI adenocarcinoma.The mechanism of action of this fluoropyrimidine deoxynucleosideanalog involves metabolic conversion to 5-fluorouracil(5-FU) metabolites resulting in inhibition of TSthus disrupting DNA synthesis, function, and repair.Resistance can occur because of increased expression of TS,decreased levels of reduced folate 5,10-methylenetetrahydrofolate,increased activity of DNA repair enzymes, and increasedexpression of dihydropyrimidine dehydrogenase(the major catabolic enzyme). The drug is poorly absorbedfrom the GI tract and is extensive metabolized to 5-FU and5-FU metabolites. Dihydropyrimidine dehydrogenase is themain enzyme responsible for 5-FU catabolism, and it ispresent in liver, GI mucosa, white blood cells, and kidney.The drug interaction and toxicity profiles are equivalent tothose of 5-FU.

General DescriptionInhibits DNA synthesis.

Upstream & downstream products

Upstream raw materials

glycoside5-FluorouracilThymidine

Related reactions

12 records
New reaction record
HRID 88609 reaction equation
HRID 88609As reactant
HRID 110515 reaction equation
HRID 110515As product
HRID 183706 reaction equation
HRID 183706As reactant
HRID 192279 reaction equation
HRID 192279As reactant
HRID 803140 reaction equation
HRID 803140As reactant
HRID 808372 reaction equation
HRID 808372As reactant
HRID 1116224 reaction equation
HRID 1116224As reactant
HRID 1121869 reaction equation
HRID 1121869As reactant
PreviousPage 1 of 2

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
2968-28-7、50-91-9、955-24-8
PubChem CID
3363
DTXSID
DTXSID70274397
ChEMBL
CHEMBL6628
ChEBI
CHEBI:94445
InChIKey
ODKNJVUHOIMIIZ-GFCOJPQKSA-N
SMILES
OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(F)C(=O)NC2=O
CAS DataBase Reference
50 · 50-91-9(CAS DataBase Reference)
NCI Dictionary of Cancer Terms
floxuridine
FDA UNII
39 LU44I5M · 039LU44I5M
NCI Drug Dictionary
floxuridine
ATC code
1 BC09 · L01BC09
NIST Chemistry Reference
2 · Uridine, 2'-deoxy-5-fluoro-(50-91-9)
EPA Substance Registry System
Floxuridine (50-91-9)
UNSPSC Code
41116107 · 41116107
NACRES
77 · NA.77
Symbol(GHS)
6 · GHS06
Signal word
Danger
Hazard statements
301 · H301
Precautionary statements
264 · P264-P270-P301+P310-P405-P501
Hazard Codes
Xn,T,Xi
Risk Statements
22 · 22-68-36/37/38-40-20/21/22
Safety Statements
22 · 22-36-36/37/39-26
RIDADR
2811 · UN 2811 6.1/PG 3
WGK Germany
3 · 3
RTECS
7525000 · YU7525000
F
10 · 10-23
Hazard Note
Toxic
HazardClass
6.1 · 6.1
PackingGroup
III
HS Code
29349990 · 29349990
Storage Class
6.1 D · 6.1D - Non-combustible acute toxic Cat.3toxic hazardous materials or hazardous materials causing chronic effects
Hazard Classifications
3 Oral · Acute Tox. 3 Oral
Hazardous Substances Data
50 · 50-91-9(Hazardous Substances Data)
Toxicity
50 oral · LD50 oral in rat: 215mg/kg
Additional notes · 1 item

DefinitionChEBI: A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.